| Size | 5 mg/25 mg |
| Synonyms | LY 2157299 |
| Purity | ≥98% |
| Formula | C22H19N5O |
| Molecule Mass | 369.43 |
| Chemical Name | 4-[5,6-Dihydro-2-(6-methyl-2-pyridinyl)-4H-pyrrolo[1,2-b]pyrazol-3-yl]-6-quinolinecarboxamide |
| SMILES | CC1=NC(C2=NN3CCCC3=C2C4=CC=NC5=C4C=C(C(N)=O)C=C5)=CC=C1 |
| Target | ALK4, ALK5 |
| Biological Activity | Galunisertib is an inhibitor of ALK4 and ALK5 (TGFβRI), with IC50 values of 77.7 nM and 172 nM, respectively. |
| Appearance | Solid |
| Color | White to yellow |
| Solubilization | The compound is soluble to 100 mM in DMSO and to 20 mM in ethanol |
| Storage | Store at -20°C |
| Shipping Information | Room temperature |
For preclinical research and development use only; not intended for therapeutic or other applications.
Alfa Cytology is a preclinical research service provider specializing in tumor organoid development. We provide one-stop services that include tailored 3D cancer models, organoid-based research services, and related products to accelerate the discovery and development of cancer therapeutics.
Copyright © 2026 Alfa Cytology. All rights reserved.